102 related articles for article (PubMed ID: 34526302)
1. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk.
Peduzzi G; Gentiluomo M; Tavano F; Arcidiacono PG; Ermini S; Vodicka P; Boggi U; Cavestro GM; Capurso G; Morelli L; Milanetto AC; Pezzilli R; Lawlor RT; Carrara S; Lovecek M; Souček P; Guo F; Hackert T; Uzunoğlu FG; Gazouli M; Párniczky A; Kupcinskas J; Bijlsma MF; Bueno-de-Mesquita B; Vermeulen R; van Eijck CHJ; Jamroziak K; Talar-Wojnarowska R; Greenhalf W; Gioffreda D; Petrone MC; Landi S; Archibugi L; Puzzono M; Funel N; Sperti C; Piredda ML; Mohelnikova-Duchonova B; Lu Y; Hlaváč V; Gao X; Schneider M; Izbicki JR; Theodoropoulos G; Bunduc S; Kreivenaite E; Busch OR; Małecka-Panas E; Costello E; Perri F; Testoni SGG; Vanella G; Pasquali C; Oliverius M; Brenner H; Loos M; Götz M; Georgiou K; Erőss B; Maiello E; Szentesi A; Bazzocchi F; Basso D; Neoptolemos JP; Hegyi P; Kiudelis V; Canzian F; Campa D
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2342-2345. PubMed ID: 34526302
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial genetic polymorphisms and pancreatic cancer risk.
Wang L; Bamlet WR; de Andrade M; Boardman LA; Cunningham JM; Thibodeau SN; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1455-9. PubMed ID: 17627010
[TBL] [Abstract][Full Text] [Related]
3. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.
Peduzzi G; Archibugi L; Katzke V; Gentiluomo M; Capurso G; Milanetto AC; Gazouli M; Goetz M; Brenner H; Vermeulen RCH; Talar-Wojnarowska R; Vanella G; Tavano F; Lucchesi M; Mohelnikova-Duchonova B; Chen X; Kiudelis V; Hegyi P; Oliverius M; Stocker H; Stornello C; Vodickova L; Souček P; Neoptolemos JP; Testoni SGG; Morelli L; Lawlor RT; Basso D; Izbicki JR; Ermini S; Kupcinskas J; Pezzilli R; Boggi U; van Laarhoven HWM; Szentesi A; Erőss B; Capretti G; Schöttker B; Skieceviciene J; Aoki MN; van Eijck CHJ; Cavestro GM; Canzian F; Campa D
Sci Rep; 2022 Oct; 12(1):18100. PubMed ID: 36302831
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
[TBL] [Abstract][Full Text] [Related]
5. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.
Pistoni L; Gentiluomo M; Lu Y; López de Maturana E; Hlavac V; Vanella G; Darvasi E; Milanetto AC; Oliverius M; Vashist Y; Di Leo M; Mohelnikova-Duchonova B; Talar-Wojnarowska R; Gheorghe C; Petrone MC; Strobel O; Arcidiacono PG; Vodickova L; Szentesi A; Capurso G; Gajdán L; Malleo G; Theodoropoulos GE; Basso D; Soucek P; Brenner H; Lawlor RT; Morelli L; Ivanauskas A; ; Kauffmann EF; Macauda A; Gazouli M; Archibugi L; Nentwich M; Loveček M; Cavestro GM; Vodicka P; Landi S; Tavano F; Sperti C; Hackert T; Kupcinskas J; Pezzilli R; Andriulli A; Pollina L; Kreivenaite E; Gioffreda D; Jamroziak K; Hegyi P; Izbicki JR; Testoni SGG; Zuppardo RA; Bozzato D; Neoptolemos JP; Malats N; Canzian F; Campa D
Carcinogenesis; 2021 Aug; 42(8):1037-1045. PubMed ID: 34216462
[TBL] [Abstract][Full Text] [Related]
6. Discovery of mitochondrial DNA variants associated with genome-wide blood cell gene expression: a population-based mtDNA sequencing study.
Laaksonen J; Seppälä I; Raitoharju E; Mononen N; Lyytikäinen LP; Waldenberger M; Illig T; Lepistö M; Almusa H; Ellonen P; Hutri-Kähönen N; Juonala M; Kähönen M; Raitakari O; Salonen JT; Lehtimäki T
Hum Mol Genet; 2019 Apr; 28(8):1381-1391. PubMed ID: 30629177
[TBL] [Abstract][Full Text] [Related]
7. A reduced number of mtSNPs saturates mitochondrial DNA haplotype diversity of worldwide population groups.
Salas A; Amigo J
PLoS One; 2010 May; 5(5):e10218. PubMed ID: 20454657
[TBL] [Abstract][Full Text] [Related]
8. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk.
Giaccherini M; Farinella R; Gentiluomo M; Mohelnikova-Duchonova B; Kauffmann EF; Palmeri M; Uzunoglu F; Soucek P; Petrauskas D; Cavestro GM; Zykus R; Carrara S; Pezzilli R; Puzzono M; Szentesi A; Neoptolemos J; Archibugi L; Palmieri O; Milanetto AC; Capurso G; van Eijck CHJ; Stocker H; Lawlor RT; Vodicka P; Lovecek M; Izbicki JR; Perri F; Kupcinskaite-Noreikiene R; Götz M; Kupcinskas J; Hussein T; Hegyi P; Busch OR; Hackert T; Mambrini A; Brenner H; Lucchesi M; Basso D; Tavano F; Schöttker B; Vanella G; Bunduc S; Petrányi Á; Landi S; Morelli L; Canzian F; Campa D
Int J Cancer; 2023 Jul; 153(2):373-379. PubMed ID: 36451333
[TBL] [Abstract][Full Text] [Related]
9. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.
Rademaker G; Hennequière V; Brohée L; Nokin MJ; Lovinfosse P; Durieux F; Gofflot S; Bellier J; Costanza B; Herfs M; Peiffer R; Bettendorff L; Deroanne C; Thiry M; Delvenne P; Hustinx R; Bellahcène A; Castronovo V; Peulen O
Oncogene; 2018 Aug; 37(32):4398-4412. PubMed ID: 29720728
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility.
Corradi C; Gentiluomo M; Gajdán L; Cavestro GM; Kreivenaite E; Di Franco G; Sperti C; Giaccherini M; Petrone MC; Tavano F; Gioffreda D; Morelli L; Soucek P; Andriulli A; Izbicki JR; Napoli N; Małecka-Panas E; Hegyi P; Neoptolemos JP; Landi S; Vashist Y; Pasquali C; Lu Y; Cervena K; Theodoropoulos GE; Moz S; Capurso G; Strobel O; Carrara S; Hackert T; Hlavac V; Archibugi L; Oliverius M; Vanella G; Vodicka P; Arcidiacono PG; Pezzilli R; Milanetto AC; Lawlor RT; Ivanauskas A; Szentesi A; Kupcinskas J; Testoni SGG; Lovecek M; Nentwich M; Gazouli M; Luchini C; Zuppardo RA; Darvasi E; Brenner H; Gheorghe C; Jamroziak K; Canzian F; Campa D
Int J Cancer; 2021 Jun; 148(11):2779-2788. PubMed ID: 33534179
[TBL] [Abstract][Full Text] [Related]
11. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
13. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer.
Walsh N; Zhang H; Hyland PL; Yang Q; Mocci E; Zhang M; Childs EJ; Collins I; Wang Z; Arslan AA; Beane-Freeman L; Bracci PM; Brennan P; Canzian F; Duell EJ; Gallinger S; Giles GG; Goggins M; Goodman GE; Goodman PJ; Hung RJ; Kooperberg C; Kurtz RC; Malats N; LeMarchand L; Neale RE; Olson SH; Scelo G; Shu XO; Van Den Eeden SK; Visvanathan K; White E; Zheng W; ; Albanes D; Andreotti G; Babic A; Bamlet WR; Berndt SI; Borgida A; Boutron-Ruault MC; Brais L; Brennan P; Bueno-de-Mesquita B; Buring J; Chaffee KG; Chanock S; Cleary S; Cotterchio M; Foretova L; Fuchs C; M Gaziano JM; Giovannucci E; Goggins M; Hackert T; Haiman C; Hartge P; Hasan M; Helzlsouer KJ; Herman J; Holcatova I; Holly EA; Hoover R; Hung RJ; Janout V; Klein EA; Kurtz RC; Laheru D; Lee IM; Lu L; Malats N; Mannisto S; Milne RL; Oberg AL; Orlow I; Patel AV; Peters U; Porta M; Real FX; Rothman N; Sesso HD; Severi G; Silverman D; Strobel O; Sund M; Thornquist MD; Tobias GS; Wactawski-Wende J; Wareham N; Weiderpass E; Wentzensen N; Wheeler W; Yu H; Zeleniuch-Jacquotte A; Kraft P; Li D; Jacobs EJ; Petersen GM; Wolpin BM; Risch HA; Amundadottir LT; Yu K; Klein AP; Stolzenberg-Solomon RZ
J Natl Cancer Inst; 2019 Jun; 111(6):557-567. PubMed ID: 30541042
[TBL] [Abstract][Full Text] [Related]
14. Association between mitochondrial genetic variation and breast cancer risk: The Multiethnic Cohort.
Li Y; Giorgi EE; Beckman KB; Caberto C; Kazma R; Lum-Jones A; Haiman CA; Marchand LL; Stram DO; Saxena R; Cheng I
PLoS One; 2019; 14(10):e0222284. PubMed ID: 31577800
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals.
Gentiluomo M; Peduzzi G; Lu Y; Campa D; Canzian F
Mutagenesis; 2019 Dec; 34(5-6):395-401. PubMed ID: 31748817
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk.
Ünal P; Lu Y; Bueno-de-Mesquita B; van Eijck CHJ; Talar-Wojnarowska R; Szentesi A; Gazouli M; Kreivenaite E; Tavano F; Małecka-Wojciesko E; Erőss B; Oliverius M; Bunduc S; Nóbrega Aoki M; Vodickova L; Boggi U; Giaccherini M; Kondrackiene J; Chammas R; Palmieri O; Theodoropoulos GE; Bijlsma MF; Basso D; Mohelnikova-Duchonova B; Soucek P; Izbicki JR; Kiudelis V; Vanella G; Arcidiacono PG; Włodarczyk B; Hackert T; Schöttker B; Uzunoglu FG; Bambi F; Goetz M; Hlavac V; Brenner H; Perri F; Carrara S; Landi S; Hegyi P; Dijk F; Maiello E; Capretti G; Testoni SGG; Petrone MC; Stocker H; Ermini S; Archibugi L; Gentiluomo M; Cavestro GM; Pezzilli R; Di Franco G; Milanetto AC; Sperti C; Neoptolemos JP; Morelli L; Vokacova K; Pasquali C; Lawlor RT; Bazzocchi F; Kupcinskas J; Capurso G; Campa D; Canzian F
Hum Genomics; 2024 Feb; 18(1):12. PubMed ID: 38308339
[TBL] [Abstract][Full Text] [Related]
17. The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction.
Tan Z; Lei Y; Xu J; Shi S; Hua J; Zhang B; Meng Q; Liu J; Zhang Y; Wei M; Yu X; Liang C
Aging (Albany NY); 2020 Nov; 12(23):24228-24241. PubMed ID: 33226369
[TBL] [Abstract][Full Text] [Related]
18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma.
Inokuchi S; Itoh S; Yoshizumi T; Yugawa K; Yoshiya S; Toshima T; Takeishi K; Iguchi T; Sanefuji K; Harada N; Sugimachi K; Ikegami T; Kohashi K; Taguchi K; Yonemasu H; Fukuzawa K; Oda Y; Mori M
Pancreatology; 2020 Sep; 20(6):1175-1182. PubMed ID: 32741713
[TBL] [Abstract][Full Text] [Related]
20. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
